Carmignac Gestion »

Terns Pharmaceuticals shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 54k 52.72

More positions owned by Carmignac Gestion

NVIDIA Corporation (NVDA)
MercadoLibre (MELI)
S&p Global (SPGI)
Alphabet Cap Stk Cl A (GOOGL)
AmerisourceBergen (COR)
Amazon (AMZN)
McKesson Corporation (MCK)
Tradeweb Markets Cl A (TW)
Berkshire Hathaway CL B (BRK.B)
Block Cl A (XYZ)
Mastercard Cl A (MA)
salesforce (CRM)
Intercontinental Exchange (ICE)
Atlassian Corp Cl A (TEAM)
Broadcom (AVGO)

View all positions for Carmignac Gestion

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
venBio Select Advisor
Vanguard Capital Management
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management
Glazer Capital
Paradigm Biocapital Advisors

View all funds holding Terns Pharmaceuticals